Cardiology care
Auth57 · Specialty PA Pack

Cardiology

For the cardiologist on DOACs, PCSK9s, and PAH therapy — what needs PA (often less than you'd think), and how to appeal.

Structured rules
3,924
PA-required
43%
Appeal layer
51/51
Criteria docs
49/51
The breadth · all 51 jurisdictions

Every state, quantified for cardiology

StateRulesPA-requiredAppealCriteria docs
AKAlaska4947%2
ALAlabama8043%10
ARArkansas9245%7
AZArizona8549%7
CACalifornia9138%8
COColorado8138%13
CTConnecticut8142%6
DCDistrict of Columbia8138%11
DEDelaware7844%4
FLFlorida8244%3
GAGeorgia9337%20
HIHawaii8539%6
IAIowa8444%11
IDIdaho5843%4
ILIllinois8041%1
INIndiana8046%5
KSKansas8041%10
KYKentucky9042%4
LALouisiana7345%8
MAMassachusetts6943%3
MDMaryland7238%12
MEMaine7240%3
MIMichigan7449%8
MNMinnesota6045%1
MOMissouri9646%4
MSMississippi8942%17
MTMontana5746%1
NCNorth Carolina9247%20
NDNorth Dakota5638%1
NENebraska7645%6
NHNew Hampshire7446%
NJNew Jersey7738%5
NMNew Mexico6138%7
NVNevada7341%18
NYNew York8545%7
OHOhio9048%14
OKOklahoma9348%4
OROregon8843%5
PAPennsylvania7442%14
RIRhode Island5840%3
SCSouth Carolina8043%8
SDSouth Dakota5334%3
TNTennessee8142%6
TXTexas9047%62
UTUtah8549%18
VAVirginia8839%9
VTVermont4943%10
WAWashington8940%11
WIWisconsin8048%3
WVWest Virginia6549%
WYWyoming5542%6
Free preview· Texas

What a fully-unlocked state looks like

medicaid ffs
  • anticoagulants doacPA requiredTX Medicaid PDL: non-preferred agents require PA (step therapy). Source: Acentra TX PDL Criteria Guide 2026-01-30 (official companion to TX Medicaid PDL).
  • antiplateletsPA requiredTX Medicaid PDL: non-preferred agents require PA (step therapy). Source: Acentra TX PDL Criteria Guide 2026-01-30 (official companion to TX Medicaid PDL).
  • statinsPA requiredTX Medicaid PDL: non-preferred agents require PA (step therapy). Source: Acentra TX PDL Criteria Guide 2026-01-30 (official companion to TX Medicaid PDL).
  • pcsk9 inhibitorsPA requiredTX Medicaid PDL: non-preferred agents require PA (step therapy). Source: Acentra TX PDL Criteria Guide 2026-01-30 (official companion to TX Medicaid PDL).
  • pulmonary arterial hypertensionPA requiredTX Medicaid PDL: non-preferred agents require PA (step therapy). Source: Acentra TX PDL Criteria Guide 2026-01-30 (official companion to TX Medicaid PDL).
commercial regulated
  • statins(UnitedHealthcare)No PAUnitedHealthcare commercial (Advantage 3-Tier). Statin subset within Cardiovascular heading; generics tier 1, H-PA/H preventive flags only, no standard PA/ST [e.g. atorvastatin, rosuvastatin, simvastatin, pravastatin]
  • anticoagulants doac(UnitedHealthcare)No PAUnitedHealthcare commercial (Advantage 3-Tier). Anticoagulants-blood clots; QL only on DOACs, no PA/ST [e.g. ELIQUIS, XARELTO, dabigatran, rivaroxaban]
  • pulmonary arterial hypertension(UnitedHealthcare)PA requiredUnitedHealthcare commercial (Advantage 3-Tier). Respiratory-pulmonary hypertension; all carry PA+QL+SP (TYVASO PA+SP) [e.g. ADEMPAS, OPSUMIT, TYVASO, TADLIQ]
  • pcsk9 inhibitors(UnitedHealthcare)No PAUnitedHealthcare commercial (Advantage 3-Tier). PCSK9 subset within Cardiovascular heading; REPATHA carries QL only here, no PA [e.g. REPATHA]
  • antiplatelets(UnitedHealthcare)No PAUnitedHealthcare commercial (Advantage 3-Tier). Antiplatelets-heart attack/stroke; QL only on ticagrelor, no PA/ST [e.g. clopidogrel, ticagrelor, prasugrel, cilostazol]
  • pcsk9 inhibitors(Cigna)No PACigna commercial (Advantage 3-Tier). REPATHA listed without PA/ST in this plan [e.g. REPATHA]
  • statins(Cigna)No PACigna commercial (Advantage 3-Tier). statins open (PPACA/QL); LIPOFEN/TRICOR fibrate=ST [e.g. atorvastatin, rosuvastatin, simvastatin, pravastatin]
  • arbs(Cigna)PA requiredCigna commercial (Advantage 3-Tier). oral ARBs mostly open but ARBLI=PA, valsartan oral soln/DIOVAN=ST [e.g. losartan, valsartan, irbesartan, ARBLI]
  • beta blockers(Cigna)No PACigna commercial (Advantage 3-Tier). beta blockers open (QL only) [e.g. metoprolol er, carvedilol, atenolol, nebivolol]
  • anticoagulants doac(Cigna)No PACigna commercial (Advantage 3-Tier). DOACs/warfarin open in blood thinners section [e.g. ELIQUIS, XARELTO, dabigatran, warfarin]
  • ace inhibitors(Cigna)No PACigna commercial (Advantage 3-Tier). ACE inhibitors open [e.g. lisinopril, enalapril, lisinopril-hctz]
  • pulmonary arterial hypertension(Cigna)PA requiredCigna commercial (Advantage 3-Tier). PAH agents in respiratory section, SP+PA [e.g. ADEMPAS, OPSUMIT, TRACLEER, TYVASO]
  • antiplatelets(Cigna)No PACigna commercial (Advantage 3-Tier). antiplatelets open [e.g. clopidogrel, prasugrel, ZONTIVITY]
  • arbs(Aetna (CVS Caremark))No PAAetna (CVS Caremark) commercial formulary. ARBs + combos, open generics [e.g. losartan, valsartan, olmesartan, irbesartan]
  • pulmonary arterial hypertension(Aetna (CVS Caremark))PA requiredAetna (CVS Caremark) commercial formulary. specialty PAH, PA standard [e.g. sildenafil (PAH), tadalafil (PAH), ambrisentan, bosentan]
  • anticoagulants doac(Aetna (CVS Caremark))No PAAetna (CVS Caremark) commercial formulary. anticoagulants/blood thinners, brand DOACs preferred; some ST [e.g. apixaban (ELIQUIS), rivaroxaban (XARELTO), warfarin, dabigatran]
  • statins(Aetna (CVS Caremark))No PAAetna (CVS Caremark) commercial formulary. HMG-CoA reductase inhibitors, open generics [e.g. atorvastatin, rosuvastatin, simvastatin, pravastatin]
  • antiplatelets(Aetna (CVS Caremark))No PAAetna (CVS Caremark) commercial formulary. platelet aggregation inhibitors, open generics; BRILINTA brand [e.g. clopidogrel, prasugrel, ticagrelor (BRILINTA), aspirin-dipyridamole]
  • ace inhibitors(Aetna (CVS Caremark))No PAAetna (CVS Caremark) commercial formulary. open generics incl ACE combos [e.g. lisinopril, enalapril, benazepril, ramipril]
  • pcsk9 inhibitors(Aetna (CVS Caremark))PA requiredAetna (CVS Caremark) commercial formulary. specialty PSP; PA + step after statins standard [e.g. REPATHA (evolocumab), PRALUENT (alirocumab)]
  • beta blockers(Aetna (CVS Caremark))No PAAetna (CVS Caremark) commercial formulary. beta-blockers + diuretic combos, open generics [e.g. metoprolol, carvedilol, atenolol, propranolol]
  • statins(Anthem Blue Cross (Elevance))No PAAnthem Blue Cross (Elevance) commercial formulary. HMG-CoA reductase inhibitors: no PA, open [e.g. atorvastatin, rosuvastatin, simvastatin, pravastatin]
  • beta blockers(Anthem Blue Cross (Elevance))No PAAnthem Blue Cross (Elevance) commercial formulary. Alpha-beta/cardioselective/nonselective: QL only, open [e.g. metoprolol, carvedilol, atenolol, propranolol]
  • anticoagulants doac(Anthem Blue Cross (Elevance))PA requiredAnthem Blue Cross (Elevance) commercial formulary. Direct factor Xa inhibitors: PA on some agents (Eliquis QL-only but class carries PA+ST) [e.g. rivaroxaban, SAVAYSA edoxaban, apixaban (ELIQUIS)]
  • pcsk9 inhibitors(Anthem Blue Cross (Elevance))PA requiredAnthem Blue Cross (Elevance) commercial formulary. PCSK9 inhibitors carry PA + QL [e.g. alirocumab, evolocumab (REPATHA/PRALUENT)]
  • pulmonary arterial hypertension(Anthem Blue Cross (Elevance))PA requiredAnthem Blue Cross (Elevance) commercial formulary. Prostaglandin vasodilators, endothelin receptor antagonists, PDE5, sGC stimulators: PA + SP [e.g. treprostinil, ambrisentan, tadalafil (ALYQ), ADEMPAS riociguat]
  • ace inhibitors(Anthem Blue Cross (Elevance))No PAAnthem Blue Cross (Elevance) commercial formulary. ACE inhibitors + combos: open [e.g. lisinopril, enalapril, benazepril, ramipril]
  • antiplatelets(Anthem Blue Cross (Elevance))No PAAnthem Blue Cross (Elevance) commercial formulary. P2Y12/thienopyridine/platelet inhibitors: QL only, open [e.g. clopidogrel, ticagrelor, prasugrel, dipyridamole]
  • arbs(Anthem Blue Cross (Elevance))No PAAnthem Blue Cross (Elevance) commercial formulary. Angiotensin II receptor antagonists + combos: QL only, open [e.g. losartan, valsartan, irbesartan, olmesartan]
part d
  • arbs(Humana)No PAHumana Part D (CMS formulary file, plan-grounded).
  • ace inhibitors(Centene)No PACentene Part D (CMS formulary file, plan-grounded).
  • arbs(Centene)No PACentene Part D (CMS formulary file, plan-grounded).
  • beta blockers(Centene)No PACentene Part D (CMS formulary file, plan-grounded).
  • pulmonary arterial hypertension(Centene)PA requiredCentene Part D (CMS formulary file, plan-grounded).
  • antiplatelets(Centene)PA requiredCentene Part D (CMS formulary file, plan-grounded).
  • pcsk9 inhibitors(Centene)PA requiredCentene Part D (CMS formulary file, plan-grounded).
  • statins(Centene)No PACentene Part D (CMS formulary file, plan-grounded).
  • anticoagulants doac(Centene)No PACentene Part D (CMS formulary file, plan-grounded).
  • antiplatelets(Unitedhealthcare)PA requiredUnitedhealthcare Part D (CMS formulary file, plan-grounded).
  • arbs(Unitedhealthcare)No PAUnitedhealthcare Part D (CMS formulary file, plan-grounded).
  • anticoagulants doac(Unitedhealthcare)No PAUnitedhealthcare Part D (CMS formulary file, plan-grounded).
  • ace inhibitors(Unitedhealthcare)No PAUnitedhealthcare Part D (CMS formulary file, plan-grounded).
  • pulmonary arterial hypertension(Unitedhealthcare)PA requiredUnitedhealthcare Part D (CMS formulary file, plan-grounded).
  • beta blockers(Unitedhealthcare)No PAUnitedhealthcare Part D (CMS formulary file, plan-grounded).
  • statins(Unitedhealthcare)No PAUnitedhealthcare Part D (CMS formulary file, plan-grounded).
  • pcsk9 inhibitors(Unitedhealthcare)PA requiredUnitedhealthcare Part D (CMS formulary file, plan-grounded).
  • ace inhibitors(Humana)No PAHumana Part D (CMS formulary file, plan-grounded).
  • anticoagulants doac(Humana)PA requiredHumana Part D (CMS formulary file, plan-grounded).
  • pulmonary arterial hypertension(Humana)PA requiredHumana Part D (CMS formulary file, plan-grounded).
  • statins(Humana)PA requiredHumana Part D (CMS formulary file, plan-grounded).
  • beta blockers(Humana)No PAHumana Part D (CMS formulary file, plan-grounded).
  • antiplatelets(Humana)PA requiredHumana Part D (CMS formulary file, plan-grounded).
  • pcsk9 inhibitors(Humana)PA requiredHumana Part D (CMS formulary file, plan-grounded).
  • anticoagulants doac(Cigna)No PACigna Part D (CMS formulary file, plan-grounded).
  • arbs(Cigna)No PACigna Part D (CMS formulary file, plan-grounded).
  • ace inhibitors(Cigna)No PACigna Part D (CMS formulary file, plan-grounded).
  • antiplatelets(Cigna)PA requiredCigna Part D (CMS formulary file, plan-grounded).
  • beta blockers(Cigna)No PACigna Part D (CMS formulary file, plan-grounded).
  • pulmonary arterial hypertension(Cigna)PA requiredCigna Part D (CMS formulary file, plan-grounded).
  • statins(Cigna)No PACigna Part D (CMS formulary file, plan-grounded).
  • pcsk9 inhibitors(Cigna)PA requiredCigna Part D (CMS formulary file, plan-grounded).
  • statins(Aetna)No PAAetna Part D (CMS formulary file, plan-grounded).
  • pcsk9 inhibitors(Aetna)PA requiredAetna Part D (CMS formulary file, plan-grounded).
  • ace inhibitors(Aetna)No PAAetna Part D (CMS formulary file, plan-grounded).
  • antiplatelets(Aetna)PA requiredAetna Part D (CMS formulary file, plan-grounded).
  • beta blockers(Aetna)No PAAetna Part D (CMS formulary file, plan-grounded).
  • anticoagulants doac(Aetna)No PAAetna Part D (CMS formulary file, plan-grounded).
  • arbs(Aetna)No PAAetna Part D (CMS formulary file, plan-grounded).
  • pulmonary arterial hypertension(Aetna)PA requiredAetna Part D (CMS formulary file, plan-grounded).
commercial qhp
  • beta blockers(Marketplace QHP (aggregate))PA requiredACA marketplace QHP — aggregated across the state's exchange issuers (PA if any issuer gates the class). Source: CMS machine-readable formulary PUF.
  • pulmonary arterial hypertension(Marketplace QHP (aggregate))PA requiredACA marketplace QHP — aggregated across the state's exchange issuers (PA if any issuer gates the class). Source: CMS machine-readable formulary PUF.
  • anticoagulants doac(Marketplace QHP (aggregate))PA requiredACA marketplace QHP — aggregated across the state's exchange issuers (PA if any issuer gates the class). Source: CMS machine-readable formulary PUF.
  • ace inhibitors(Marketplace QHP (aggregate))PA requiredACA marketplace QHP — aggregated across the state's exchange issuers (PA if any issuer gates the class). Source: CMS machine-readable formulary PUF.
  • pcsk9 inhibitors(Marketplace QHP (aggregate))PA requiredACA marketplace QHP — aggregated across the state's exchange issuers (PA if any issuer gates the class). Source: CMS machine-readable formulary PUF.
  • arbs(Marketplace QHP (aggregate))PA requiredACA marketplace QHP — aggregated across the state's exchange issuers (PA if any issuer gates the class). Source: CMS machine-readable formulary PUF.
  • statins(Marketplace QHP (aggregate))PA requiredACA marketplace QHP — aggregated across the state's exchange issuers (PA if any issuer gates the class). Source: CMS machine-readable formulary PUF.
  • antiplatelets(Marketplace QHP (aggregate))PA requiredACA marketplace QHP — aggregated across the state's exchange issuers (PA if any issuer gates the class). Source: CMS machine-readable formulary PUF.
  • anticoagulants doac(Molina Healthcare)No PAMolina Healthcare commercial formulary. Eliquis/Xarelto (Direct Factor Xa) QL only, no PA/ST
  • statins(Molina Healthcare)PA requiredMolina Healthcare commercial formulary. fluvastatin ER ST plus a PA; most statins open
  • antiplatelets(Molina Healthcare)PA requiredMolina Healthcare commercial formulary. P2Y12, platelet-aggregation and PAR-1 inhibitors carry PA; thienopyridines open
  • pcsk9 inhibitors(Molina Healthcare)PA requiredMolina Healthcare commercial formulary. 3 PA flags in PCSK9 inhibitor section
  • ace inhibitors(Molina Healthcare)No PAMolina Healthcare commercial formulary. ACE Inhibitors section open, no PA/ST
  • beta blockers(Molina Healthcare)No PAMolina Healthcare commercial formulary. Cardioselective/non-selective/alpha-beta blockers all open
  • pulmonary arterial hypertension(Molina Healthcare)PA requiredMolina Healthcare commercial formulary. Prostaglandin vasodilators / PAH agents carry 14 PA
  • arbs(Molina Healthcare)No PAMolina Healthcare commercial formulary. Angiotensin II Receptor Antagonists section open
If denied in Texas
📨 Program Support Unit (PSU)
Unlock the full pack

Full criteria, sources & appeal paths — all 51 states.

You’ve seen the breadth and one state in full. The complete Cardiologypack — every state’s criteria, source citations, and step-by-step appeal instructions — is one email away.

We'll never sell or share your email.

Assembled from Auth57’s rules + criteria corpus + 51-state appeal layer. Draft data — verify against the payer’s current policy before relying.